164 results
Page 4 of 9
6-K
EX-99.2
d8n9e k2ra
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
gw9mii
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
hd7dw
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
31qeb
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
a4ia001y
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.1
1px6ove op
30 Nov 20
RepliCel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis
10:05am
6-K
EX-99.2
qbjyqqdnegh67hr
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am
6-K
EX-99.1
36dvyuioyh6gi 7b
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am
6-K
EX-99.2
1dtbonetsf3wpt1c
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.3
k7avvs5djp5v3mu
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm
6-K
EX-99.2
itcqhf fw846m78x5w
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm
6-K
EX-99.1
xqsyeju18qrged zjob
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm
6-K
EX-99.3
x124en
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.2
80i1s5 irhrpd4
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.4
26dd5 k6euxc2ki3vl
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.2
wina 7caun
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
vpi32b3o
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.1
1eddg
23 Dec 19
RepliCel Announces its Incoming Board of Directors
5:21pm